Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution

Leukemia and Lymphoma

Volumn 51, Issue 6, 2010, Pages 1063-1071

  Parasole, Rosanna ^a   Petruzziello, Fara ^a   Menna, Giuseppe ^a   Mangione, Argia ^a   Cianciulli, Emilio ^b   Buffardi, Salvatore ^a   Marchese, Luciano ^a   Nastro, Anna ^b   Misuraca, Aldo ^a   Poggi, Vincenzo ^a  

^a Santobono Pausilipon Hospital   (Italy)

^b SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

Author keywords

Acute lymphoblastic leukemia; Chemotherapy; Childhood; CNS complications; Posterior reversible leukoencephalopathy; Symptomatic seizures

Indexed keywords

ASPARAGINASE; DAUNORUBICIN; DEXAMETHASONE; METHOTREXATE; VINCRISTINE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; MERCAPTOPURINE; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; INAPPROPRIATE VASOPRESSIN SECRETION; MALE; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STROKE; TEMPORAL LOBE EPILEPSY; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; CHEMICALLY INDUCED; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECTS; ELECTROENCEPHALOGRAPHY; INFANT; LEUKEMIC INFILTRATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM DISEASES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDY;

6-MERCAPTOPURINE; ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; INFANT; LEUKEMIC INFILTRATION; MAGNETIC RESONANCE IMAGING; MALE; METHOTREXATE; PERIPHERAL NERVOUS SYSTEM DISEASES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; VINCRISTINE;

EID: 77953486368     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428191003754608     Document Type: Article

References (16)

1. Aricò M, Valsecchi MG, Rizzari C, et al. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt- Muenster based chemotherapy. J Clin Oncol 2008;26:283-289.
2. Chen CY, Zimmerman RA, Faro S, Bilaniuk LT, Chou T, Molloy PT. Childhood leukemia: central nervous system abnormalities during and after treatment. AJNR Am J Neuroradiol 1996;17:295-310.
3. Ochs JJ. Neurotoxicity due to central nervous system therapy for childhood leukemia. Am J Pediatr Hematol Oncol 1989; 11:95-105.
4. Ray M, Marwaha RK, Trehan A. Chemotherapy related fatal neurotoxicity during induction in acute lymphoblastic leukemia. Indian J Pediatr 2002;69:185-187.
5. Aytac S, Yetgin S, Tavil B. Acute and long-term neurologic complications in children with acute lymphoblastic leukemia. Turk J Pediatr 2006;48:1-7.
6. Flohr T, Scrauder A, Cazzaniga G, et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOPBFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 2008;22:771-782.
7. Conter V, Bartram CR, Valsecchi MG, et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOPBFM ALL 2000 study. Blood 2010 Feb 12. [Epub ahead of print].
8. Walker RW, Allen JC, Rosen G, Caparros B. Transient cerebral dysfunction secondary to high-dose methotrexate. J Clin Oncol 1986;4:1845-1850.
9. Hinchey J, Chaves C, Appignani B. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
10. Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 2001;24:361-364.
11. Antunes NL, Small TN, George D, Boulad F, Lis E. Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol 1999;20:241-243.
12. Prasad N, Gulati S, Gupta RK, Kumar R, Sharma K, Sharma RH. Is reversible posterior leukoencephalopathy with severe hypertension completely reversible in all patients? Pediatr Nephrol 2003;18:1161-1166.
13. D'Angelo P, Farruggia P, Lo Bello A, et al. Reversible posterior leukoencephalopathy syndrome. Report of 2 simultaneous cases in children. J Pediatr Hematol Oncol 2006; 28:177-181.
14. Morris EB, Laningham FH, Sandlund JT, Khan RB. Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer 2007;48:152-159.
15. Lucchini G, Grioni D, Colombini A, et al. Encephalopathy syndrome in children with hemato-oncological disorders is not always posterior and reversible. Pediatr Blood Cancer 2008; 51:629-633.
16. Vezmar S, Becker A, Bone U, Jachde U. Biochemical and clinical aspects of methotrexate neurotoxicity. Chemotherapy 2003;49:92-104.